Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
ABC-AF Bleeding ScoreABC-AF Stroke ScoreABCD2 ScoreADD-RSAortic Valve Calcium ScoreAPPLE ScoreASCVD (Pooled Cohort)AVA (Continuity Equation)BAG-AHF ScoreBiplane Simpson EFBlood Pressure PercentilesBrugada Criteria (VT vs SVT)Cardiac Output IndexCHA2DS2-VAScCHADS2Cornell Voltage CriteriaCRUSADE Bleeding ScoreDAPT ScoreDASIDuke Treadmill ScoreE/A RatioEDACS ScoreEHMRGEHRA ScoreEmbolic Risk ScoreEROA (PISA Method)FFR (Fractional Flow Reserve)Fick Cardiac OutputFramingham 10-Year RiskFriedewald LDL EquationGorlin EquationGRACE ScoreGupta MICA (NSQIP)GWTG-HF ScoreH2FPEF ScoreHakki FormulaHAS-BLEDHEART PathwayHEART ScoreHEMORR2HAGEShs-Troponin 0h/1h ESC AlgorithmiFRINTERCHEST ScoreKillip ClassificationLee's RCRILV Mass IndexLV Stroke Work IndexMAGGIC Risk ScoreMAP CalculatorMartin/Hopkins LDLModified Duke CriteriaModified Sgarbossa CriteriaMVA (Pressure Half-Time)Non-HDL CholesterolNT-proBNP Age-Adjusted ThresholdsORBIT ScoreOttawa Heart Failure RiskPREVENT EquationsPulse PressurePVR CalculatorPVR IndexQRISK3QTc (Bazett)QTc (Fridericia)REVEAL 2.0 ScoreREVEAL Lite 2Reynolds Risk ScoreROSIRVSP CalculatorSchwartz Score (LQTS)SCORE2Seattle Heart Failure Model (SHFM)Sgarbossa CriteriaShock IndexSokolow-Lyon VoltageStroke Volume IndexSVR CalculatorSYNTAX ScoreSYNTAX Score IITAPSETeichholz FormulaTIMI (STEMI)TIMI (UA/NSTEMI)Troponin Delta CalculatorValvular GradientsVancouver Chest Pain RuleVereckei AlgorithmWATCHDM ScoreWilkins ScoreWood Units Calculator
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2026

•

All Rights Reserved

hs-Troponin 0h/1h ESC Algorithm

Guidelines & Evidence

Verified

Last Review: 2026-07-17

When to Use

Target Population

Hemodynamically stable patients presenting to the ED with suspected NSTEACS.
Initial 12-lead ECG (within 10 min) must exclude ST-segment elevation (STEMI).
Symptoms suggestive of MI (chest pain, pressure, or atypical equivalents).

Exclusion Criteria

ST-segment elevation (STEMI) or acute vessel obstruction on ECG.
Unstable/hemodynamically compromised patients.
Unselected ED populations (e.g., primary sepsis or stroke without cardiac suspicion).

How it Works

Analytical Logic

The 0h/1h algorithm relies on two principles: (1) Baseline concentration correlates with MI probability, and (2) absolute change (kinetics) within 1 hour serves as a surrogate for 3-6 hour changes (e.g., a 6 ng/L 3h-rise suggests a 2 ng/L 1h-rise).

Assay-Specific Cut-offs (ng/L)

Assay PlatformVery Low (0h)Rule-Out (0h/1h Δ)Rule-In (0h / 1h Δ)
Roche Elecsys (hs-cTnT)< 5< 12 AND Δ < 3≥ 52 OR Δ ≥ 5
Abbott Architect (hs-cTnI)< 4< 5 AND Δ < 2≥ 64 OR Δ ≥ 6
Siemens Centaur (hs-cTnI)< 3< 6 AND Δ < 3≥ 120 OR Δ ≥ 12
Beckman Access (hs-cTnI)< 4< 5 AND Δ < 4≥ 50 OR Δ ≥ 15

Temporal Requirements

T0: Time of first blood draw at presentation.
T1: Second blood draw exactly 60 minutes (± 10 min) after T0.
Algorithm remains valid regardless of local laboratory turnaround time (TAT).

Origins & History

Developmental History

2011: ESC introduced the 0h/3h algorithm (NPV >98% if 0h/3h <99th percentile + GRACE <140).
2015: 0h/1h algorithm introduced to reduce the "troponin-blind" interval and improve ED efficiency.
Verification: Validated in the APACE cohort (12 EDs, 5 countries) and the randomized RAPID-TnT trial.
Class Recommendation: Class I, Level A (ESC 2020) for 0h/1h; 0h/3h is now Class IIa alternative.

The "Requiem" for Unstable Angina

With the advent of hs-cTn assays (10-fold lower Limit of Detection), many patients previously diagnosed with Unstable Angina (UA) are now correctly identified as NSTEMI. This has led to a reciprocal reduction in UA prevalence.

Clinical Pearls

Predictive Performance

Rule-Out Zone: Safety quantified by NPV >99% and sensitivity >99% for NSTEMI.
Rule-In Zone: Positive Predictive Value (PPV) ~70-75%. Note: 25-30% of rule-ins may be non-MI cardiac injury (Myocarditis, Takotsubo).
Observe Zone: High-risk group; mortality rates at 2 years are comparable to Rule-In patients.

Demographic Variables

Age: Elevated hs-cTn prevalence is 1% at age 40 vs 5.2% at age 65.
Renal Function: Requires careful interpretation as baseline levels are often chronically elevated.

Next Steps

Observe Zone Protocol

Considered "Observe" if meeting neither Rule-In nor Rule-Out criteria.
Mandatory: 3-hour hs-cTn measurement.
Next Steps: Echocardiography, then non-invasive (CCTA/Stress) or invasive (CAG) based on clinical suspicion.

Disposition Strategy

Rule-Out: Candidate for early discharge if pain-free and life-threats (Aortic Dissection/PE) are excluded.
Rule-In: CCU admission, DAPT loading, and early invasive coronary angiography.

The Evidence

Key Implementation Trials

Literature References

Last Comprehensive Review: 2026-07-17

In Recent Clinical News

Scanning Medical Journals

No new significant updates or guidelines matching this topic were found today. We will check again soon.